The novel treatment of this peptide represents a significant breakthrough in the care of diabetes mellitus type 2. Distinct from existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 https://tirzepatidepeptide082913.blue-blogs.com/50278102/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment